Monopar Therapeutics Inc. · NASDAQ:MNPR
Anderson Raymond sold 3,142 Monopar Therapeutics Inc. shares (Form 4/A)
Traded Aug 25, 2026 · Filed Aug 28, 2026
On Aug 25, 2026, Anderson Raymond (Director) sold 3,142 Monopar Therapeutics Inc. shares at an average US$111.98 for US$352K under a trading plan, leaving 5,373 shares. Filed Aug 28, 2026 (Form 4/A).
- Sold
- 3,142 shares
- Price
- US$111.98 average (US$110.04 to US$113.05)
- Value
- US$352K
- Holding after
- 5,373 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | Option exercise | 1,402 | US$30.00 | 6,775 | Direct |
| Aug 25, 2026 | Common Stock | Option exercise | 1,740 | US$30.00 | 8,515 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 694 | US$110.04 | 7,821 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 646 | US$111.07 | 7,175 | Direct |
| Aug 25, 2026 | Common Stock | Sale | 1,802 | US$113.05 | 5,373 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Anderson Raymond
- Monopar Therapeutics Inc. shareholders
- Form 4 · Anderson Raymond · Aug 27, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026